Catalent Inc
F:0C8
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Catalent Inc
F:0C8
|
US |
|
A
|
Altair Resources Inc
F:90AA
|
CA |
|
C
|
Chiyoda Corp
F:CYA
|
JP |
|
G
|
Genovate Biotechnology Co Ltd
TPEX:4130
|
TW |
|
U
|
Userjoy Technology Co Ltd
TPEX:3546
|
TW |
|
Eledon Pharmaceuticals Inc
F:2TK
|
US |
|
S
|
SynAct Pharma AB
F:8F8
|
SE |
|
Pasinex Resources Ltd
F:PNX
|
CA |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0C8's stock price target?
Not Available
0C8 does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Catalent Inc?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 3 years is 8%.